Duality

Former NSA Director Joins Duality Advisory Board

Retrieved on: 
Tuesday, February 21, 2023
Organization, CSS, OpenFHE, Government, Trust, Central Security Service, Security agency, ADM, Data science, United States Cyber Command, Safety, FHE, Privacy and the US government, Privacy, Security Service, United, Interview, USCYBERCOM, NSA, DARPA, AI, History, Cryptocurrency, Duality

HOBOKEN, N.J., Feb. 21, 2023 /PRNewswire/ -- Duality Technologies, the leader in privacy preserving data collaboration is proud to announce that Adm. Michael Rogers (ret.), former commander of the United States Cyber Command (USCYBERCOM), director of the National Security Agency (NSA) and chief of the Central Security Service (CSS), has joined the Duality esteemed board of advisors. 

Key Points: 
  • ), former commander of the United States Cyber Command (USCYBERCOM), director of the National Security Agency (NSA) and chief of the Central Security Service (CSS), has joined the Duality esteemed board of advisors.
  • "I am excited to join Duality's advisory board to support the company's mission of delivering advanced data protection capabilities that enable organizations in public and private sectors to collaborate on their sensitive data.
  • "We are delighted to welcome to our advisory board Adm. Rogers, who has dedicated his government career to cyber defense and security," said Rina Shainski, Duality's chairwoman and co-founder.
  • For more information on Duality and Adm. Rogers vision on trust and security in data collaborations – please listen to this interview .

DARPA Awards Duality Technologies Multimillion Dollar Contract to Accelerate Machine Learning on Encrypted Data

Retrieved on: 
Tuesday, January 10, 2023
Email encryption, Partnership, Government, ML, Research, Department of Defence, Organization, United States Department of Defense, Star Trek: Phase II, DARPA, Privacy, Privacy and the US government, Machine learning, Interview, Unitary state, FHE, Data science, Satellite navigation device, Duality

HOBOKEN, N.J. , Jan. 10, 2023 /PRNewswire/ -- Duality Technologies, the leader in privacy preserving data collaboration, today announced that the company was selected for Phase II of the DARPA Data Protection in Virtual Environments (DPRIVE) program. New capabilities for accelerated privacy-protected machine learning developing in the project will be integrated into Duality Technology's secure data collaboration platform, offering customers the most comprehensive ability to apply data science and machine learning on sensitive data in an expedient and collaborative way that further breaks down data silos that exist within and between organizations.

Key Points: 
  • New capabilities for accelerated privacy-protected machine learning developing in the project will be integrated into Duality Technology's secure data collaboration platform, offering customers the most comprehensive ability to apply data science and machine learning on sensitive data in an expedient and collaborative way that further breaks down data silos that exist within and between organizations.
  • This leading open source FHE software library revolutionizes computation on encrypted data - ensuring data security to address applications for the US Government, Department of Defense (DoD) and in commercial applications.
  • In Phase I, the Duality-led team designed a hardware accelerator for machine learning on data encrypted using FHE.
  • The team's successful design work in Phase I justified their selection for Phase II and the multimillion dollar research and development contract to design and prototype encrypted computing acceleration hardware.

Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform

Retrieved on: 
Thursday, January 5, 2023
Cancer, Patient, Mannose, Control, Degenerative disease, ADC, Safety, Neoplasm, Fine chemical, Vaccine, Duality

Under the terms of the agreement, Adcendo will license Duality's proprietary DITAC (Duality Immune Toxin Antibody Conjugates) linker/payload platform for its lead uPARAP-ADC program in mesenchymal cancers.

Key Points: 
  • Under the terms of the agreement, Adcendo will license Duality's proprietary DITAC (Duality Immune Toxin Antibody Conjugates) linker/payload platform for its lead uPARAP-ADC program in mesenchymal cancers.
  • Both parties are in discussions to expand the license agreement to cover additional targets selected by Adcendo.
  • Michael Pehl, Chief Executive Officer of Adcendo, said: "We are very pleased to announce this agreement to leverage Duality's DITAC platform for our first-in-class uPARAP ADC program.
  • John Zhu, Chief Executive Officer of Duality, said: "Duality is dedicated to becoming a leading next-generation ADC company.

Adcendo ApS Announces License Agreement with Duality Biologics on Next-generation ADC Platform

Retrieved on: 
Thursday, January 5, 2023
Cancer, Patient, Mannose, Control, Degenerative disease, ADC, Safety, Neoplasm, Fine chemical, Vaccine, Duality

Under the terms of the agreement, Adcendo will license Duality's proprietary DITAC (Duality Immune Toxin Antibody Conjugates) linker/payload platform for its lead uPARAP-ADC program in mesenchymal cancers.

Key Points: 
  • Under the terms of the agreement, Adcendo will license Duality's proprietary DITAC (Duality Immune Toxin Antibody Conjugates) linker/payload platform for its lead uPARAP-ADC program in mesenchymal cancers.
  • Both parties are in discussions to expand the license agreement to cover additional targets selected by Adcendo.
  • Michael Pehl, Chief Executive Officer of Adcendo, said: "We are very pleased to announce this agreement to leverage Duality's DITAC platform for our first-in-class uPARAP ADC program.
  • John Zhu, Chief Executive Officer of Duality, said: "Duality is dedicated to becoming a leading next-generation ADC company.

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

Retrieved on: 
Thursday, January 5, 2023
Cancer, Patient, Degenerative disease, ADC, Safety, Control, Neoplasm, Vaccine, Duality

Under the terms of this agreement, Adcendo will be granted the license of Duality's proprietary DITAC (Duality Immune Toxin Antibody Conjugates) platform for its lead uPARAP-ADC program in mesenchymal cancers.

Key Points: 
  • Under the terms of this agreement, Adcendo will be granted the license of Duality's proprietary DITAC (Duality Immune Toxin Antibody Conjugates) platform for its lead uPARAP-ADC program in mesenchymal cancers.
  • Both parties are discussing to expand the license to cover additional targets selected by Adcendo.
  • John Zhu, CEO of Duality, said: "Duality is dedicated to becoming a leading next-generation ADC company.
  • We are very glad to work with Adcendo on breakthrough ADC medicines and believe the collaboration reflects the mutual recognition of each party's unique strengths in ADC discovery and development.

Duality announced the appointment of Dr. Pasi A. Jänne as Member of SAB

Retrieved on: 
Thursday, December 15, 2022
Antibody-drug conjugate, MD, IND, Doctor of Philosophy, Internal medicine, Brigham and Women's Hospital, Learning, Belfer Center for Science and International Affairs, Conjugation, Patient, Science, Cancer, University, Dana–Farber Cancer Institute, NSCLC, Oncology, Lung cancer, ADC, ASCO, CSO, Disease, Degenerative disease, Reality, George M. Low Center for Industrial Innovation, AACR, ESMO, Multimedia, Clinical trial, GM, DFCI, Hospital, SAB, Dana, Harvard Medical School, EGFR, Medical device, Duality, Medicine

PRINCETON, N. J., SHANGHAI and SUZHOU, China, Dec. 15, 2022 /PRNewswire/ -- Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Pasi A. Jnne as member of SAB.

Key Points: 
  • PRINCETON, N. J., SHANGHAI and SUZHOU, China, Dec. 15, 2022 /PRNewswire/ -- Duality Biotherapeutics, Inc. ("Duality" or "the Company") today announced the appointment of Dr. Pasi A. Jnne as member of SAB.
  • Dr. Pasi Jnne is a world renowned translational thoracic medical oncologist at the Dana Farber Cancer Institute and Professor of Medicine at Harvard Medical School.
  • Dr. Jnne's research combines laboratory-based study with translational research in clinical trial of novel therapeutic agents in patients with lung cancer.
  • Dr. Yang Qiu, CSO and US GM of Duality, added, "We are very excited Dr. Pasi Jnne joined Duality SAB.

AWS Announces AWS SimSpace Weaver

Retrieved on: 
Tuesday, November 29, 2022
Robotics, Data Management, Technology, Software, Internet, Hardware, Cloud, Perfect 10, Inc. v. Amazon.com, Inc., Lockheed Martin, API, Virtual prototyping, Transport, IOT, Unreal Engine, Walk Out, Robotics, Elasticity, Environment, Kindle Direct Publishing, Virtual, Artificial intelligence, Pedestrian, Television, Amazon Web Services, AMZN, Augmented reality, Amazon Studios, VR, Machine learning, Skunk Works, Government, Amazon Fire TV, EC2, Amazon, AWS, Emergency medical services, Research, Epic Games, Internet of things, Climate, Logic, Duality, Unity, Climate Pledge Arena, Alexa, Thought, Amazon Elastic Compute Cloud, Collection, AR, Amazon Echo, Online shopping, 3D printing, Entertainment, Kindle, Unreal, Fire, Maxar Technologies

At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com , Inc. company (NASDAQ: AMZN), today announced AWS SimSpace Weaver, a fully managed compute service that helps customers build, operate, and run large-scale spatial simulations.

Key Points: 
  • At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com , Inc. company (NASDAQ: AMZN), today announced AWS SimSpace Weaver, a fully managed compute service that helps customers build, operate, and run large-scale spatial simulations.
  • There are no upfront commitments or fees to use AWS SimSpace Weaver, and customers only pay for the amount of compute used.
  • AWS SimSpace Weaver allows a variety of customers to easily run complex, immersive 3D experiences and test and visualize large-scale scenarios.
  • AWS SimSpace Weaver provides a local development environment for customers to iterate and test a version of their spatial simulation for free on their personal hardware, before running their simulation at scale on AWS.

Virtue Tattoo Fades and Removes Multicolored Tattoos with the Advanced Astanza Trinity Laser in Houston, Texas

Retrieved on: 
Monday, November 14, 2022
Marketing, Hair removal, Houston Chronicle, Tattoo, Meadows Place, Texas, Partnership, Creativity, Support, Complex Networks, Duality, VI, Ink, Laser, Houston, Ruby laser, Mineral oil

Houston, Texas, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Virtue Tattoo , voted Houstons best tattoo shop six times, now offers safe, fast, and effective laser tattoo removal featuring the Astanza Trinity laser.

Key Points: 
  • Houston, Texas, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Virtue Tattoo , voted Houstons best tattoo shop six times, now offers safe, fast, and effective laser tattoo removal featuring the Astanza Trinity laser.
  • Located in Meadows Place between Houstons Chinatown and Sugar Land, Texas, Virtue Tattoo hopes to use laser tattoo removal to transform existing tattoos, remove unwanted tattoos, and improve cover-up artwork.
  • Virtue Tattoo is home to some of Houstons most talented tattoo artists and body piercers and can now add expert laser tattoo removal to its list of services.
  • Virtue Tattoo is a full-service tattoo studio that offers elite tattooing, high-quality body piercing, and advanced laser tattoo removal.

DM Studio Brings Safe, Fast, and Effective Laser Hair Removal to McAllen, Texas featuring the Astanza MeDioStar

Retrieved on: 
Wednesday, November 2, 2022
Marketing, Face, DM, Partnership, YouTube, GLOBE, Pulse, Monolith, Human, Duality, Beauty, Laser, Hair removal, Skin, Hair, Patient satisfaction, Support, Cosmetics, Facebook

DM Studio recently added the Astanza MeDioStar laser to deliver fast, safe, and effective laser hair removal treatments for all skin types and treatment areas, even newly tanned skin.

Key Points: 
  • DM Studio recently added the Astanza MeDioStar laser to deliver fast, safe, and effective laser hair removal treatments for all skin types and treatment areas, even newly tanned skin.
  • We are so excited to introduce the Astanza MeDioStar and help clients get rid of their bothersome hair once and for all.
  • DM Studio has always been committed to services that enhance natural beauty, and we believe laser hair removal is the perfect addition to serve our clients and their needs better.
  • Their services include laser hair removal, waxing, brow and lash tint, hair styling, lash lift, microblading, haircuts, and much more.

Salvation Laser Center Transforms Cover-Up Tattoos with Advanced Astanza Duality Laser Tattoo Removal in Rowlett, Texas

Retrieved on: 
Monday, October 31, 2022
YouTube, Marketing, Skin, Partnership, Ink, Duality, Hair removal, Veteran, GLOBE, Technology, Support, Laser, Mineral oil, Facebook

Salvation Laser Center is dedicated to helping customers completely remove or partially fade existing ink to make room for new tattoos.

Key Points: 
  • Salvation Laser Center is dedicated to helping customers completely remove or partially fade existing ink to make room for new tattoos.
  • The Astanza Duality featured at Salvation Laser Center is a renowned Q-switched Nd:YAG laser.
  • We are thrilled to welcome Salvation Laser Center and Sinners Tattoo to the Astanza family, said Josh Walsh, Astanza Account Representative.
  • Salvation Laser Center is the exclusive partner of Sinners Tattoo and specializes in tattoo modification, fading for cover-up tattoos, and removing unwanted tattoos.